Skip to main content
UCB logo

UCB — Investor Relations & Filings

Ticker · UCB ISIN · BE0003739530 LEI · 2138008J191VLSGY5A09 BR Manufacturing
Open in API
Filings indexed 2,018 across all filing types
Latest filing 2020-03-02 Transaction in Own Shar…
Country BE Belgium
Listing BR UCB

About UCB

https://www.ucb.com/

UCB is a global biopharmaceutical company that focuses on creating solutions for people living with severe diseases, primarily in the fields of neurology and immunology. The company's core activities include the research, development, and commercialization of pharmaceutical and biotechnology products. Guided by a patient-centric and science-driven approach, UCB is committed to innovation and sustainability. Through its UCB Ventures arm, it invests in pioneering technologies and companies with the potential to transform patient care. The company also offers personalized support services to patients and healthcare professionals during their treatment journey with a UCB medicine.

Recent filings

Filing Released Lang Actions
200302 - Aliénation d'actions propres.pdf
Transaction in Own Shares Classification · 1% confidence The document title is "Aliénation d'actions propres" (Alienation of own shares) and the text details transactions where UCB SA alienated (sold/issued) its own shares following the exercise of options by personnel (LTI plans). This activity directly corresponds to the definition of a company buying back or selling its own shares, which is classified as 'Transaction in Own Shares'. The corresponding code is POS. The document is a formal announcement dated March 2, 2020, detailing transactions from late February 2020.
2020-03-02 French
200302- Vervreemding van eigen aandelen.pdf
Transaction in Own Shares Classification · 1% confidence The document is titled "Vervreemding van eigen aandelen" (Disposal of own shares) and details transactions where UCB NV delivered its own shares to employees following option exercises under various Long-Term Incentive (LTI) plans. This activity directly relates to the company managing its own share capital, specifically through the issuance or repurchase of shares related to employee compensation. This aligns precisely with the definition of 'Transaction in Own Shares' (POS), which covers share repurchase/issuance. Although it involves employee stock options, the core action reported is the disposal/delivery of treasury shares, making POS the most accurate fit over CAP (Capital/Financing Update) or SHA (Share Issue/Capital Change), which are broader.
2020-03-02 Dutch
200224 - Disposal of own shares.pdf
Transaction in Own Shares Classification · 1% confidence The document is explicitly titled "Disposal of own shares" and details numerous transactions where UCB SA/NV disposed of its own shares OTC in connection with employee stock option exercises (Long Term Incentive Program). This activity directly corresponds to the definition of a company buying back or selling its own shares. Therefore, the appropriate classification is Transaction in Own Shares (POS). The document is a press release/regulated information announcement, not a comprehensive report, so POS is more specific than RNS.
2020-02-24 English
200224 - Aliénation d'actions propres.pdf
Transaction in Own Shares Classification · 1% confidence The document title is "Aliénation d'actions propres" (Alienation of own shares) and the content details numerous transactions where UCB SA alienated (sold/issued) its own shares following the exercise of options by personnel, as required by Belgian Royal Decree (Article 8:6). This directly corresponds to the definition of a company reporting transactions involving its own shares, which aligns with the 'Transaction in Own Shares' category (POS). It is not a general regulatory filing (RNS) because it fits a specific category, nor is it a Director's Dealing (DIRS) as it relates to employee stock option plans rather than personal trades by directors, although there is overlap, POS is more precise for share repurchase/issuance programs. Total document length is 8547 characters, which is substantial enough to be the primary filing, not just an announcement (RPA).
2020-02-24 French
200224 - Vervreemding eigen aandelen.pdf
Transaction in Own Shares Classification · 1% confidence The document title is "Vervreemding van eigen aandelen" (Disposal of own shares). The content details transactions where UCB NV delivered its own shares to employees as part of long-term incentive plans (stock options exercised). This activity directly relates to the company managing its own share capital, specifically through the disposal/issuance of treasury stock or shares related to employee compensation plans. This aligns perfectly with the definition for 'Transaction in Own Shares' (POS), which covers share repurchase/issuance activities. It is not a general regulatory filing (RNS) because it is highly specific, nor is it a Director's Dealing (DIRS) as it relates to employee stock options rather than executive personal trades, although it is related to insider activity. The document is a specific disclosure of share transactions.
2020-02-24 Dutch
2019 annual integrated report - ENG.pdf
Annual Report Classification · 1% confidence The document is explicitly titled 'INTEGRATED ANNUAL REPORT 2019' and contains comprehensive sections including a letter to stakeholders, business performance reviews, consolidated financial statements, and governance reports. It is a full-length annual report, not an announcement or a summary, and thus fits the definition of a 10-K (Annual Report). FY 2019
2020-02-20 English

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.